Innovation Pharmaceuticals Inc (IPIX)

[biodoc]

My pleasure. Reading about OM got me curious as to how Kepivance performed in preclinical and clinical studies. A quick read gave me the sense that in animal studies it was statistically significant but not unbelievably impressive and for humans it reduces days with Grade 3 lesions or worse by about 2/3. Really good but not unbelievable. It'd be great to see some side by side results for Brilacidin and Kepivance in animal studies.

On the subject of Brilacidin, it's hard not to get excited about soon to be known skin infection results and the prospects for opthalmic and otic preparations. It really is a franchise.